What Happens to the Preserved Renal Parenchyma After Clamped Partial Nephrectomy?
Xiong L, Nguyen JK, Peng Y, Zhou Z, Ning K, Jia N, Nie J, Wen D, Wu Z, Roversi G, Palacios DA, Abramczyk E, Munoz-Lopez C, Campbell JA, Cao Y, Li W, Zhang X, He Z, Li X, Huang J, Shou J, Wu J, Chen M, Chen X, Zheng J, Xu C, Zhong W, Li Z, Dong W, Zhao J, Zhang H, Luo J, Liu J, Sun F, Han H, Guo S, Dong P, Zhou F, Yu C, Campbell SC, Zhang Z.
Eur Urol. 2022 May;81(5):492-500. doi: 10.1016/j.eururo.2021.12.036. Epub 2022 Jan 19.
PMID:35058086
Moyamoya disease with refractory hypertension associated with peripheral arterial stenosis in the renal parenchyma.
Dapagliflozin-entresto protected kidney from renal hypertension via downregulating cell-stress signaling and upregulating SIRT1/PGC-1alpha/Mfn2-medicated mitochondrial homeostasis.
Ko SF, Yang CC, Sung PH, Cheng BC, Shao PL, Chen YL, Yip HK.
Exp Biol Med (Maywood). 2023 Dec;248(23):2421-2439. doi: 10.1177/15353702231198087. Epub 2023 Dec 7.
PMID:38059322
Pediatric renal pseudotumour.
Ola D, Hanumaiah R, Majmudar A.
BJR Case Rep. 2020 Nov 19;7(2):20200088. doi: 10.1259/bjrcr.20200088. eCollection 2021 Apr 1.
PMID:33841898
Arterial hypertension in renal parenchyma diseases.
Kuska J.
Mater Med Pol. 1983 Jul-Dec;15(3-4):87-91.
PMID:6571372
Antioxidant Properties of Alpha-Lipoic (Thioctic) Acid Treatment on Renal and Heart Parenchyma in a Rat Model of Hypertension.
Martinelli I, Tomassoni D, Roy P, Di Cesare Mannelli L, Amenta F, Tayebati SK.
Antioxidants (Basel). 2021 Jun 23;10(7):1006. doi: 10.3390/antiox10071006.